Literature DB >> 7947596

Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis.

T Budde1, C Fechtrup, E Bösenberg, C Vielhauer, A Enbergs, H Schulte, G Assmann, G Breithardt.   

Abstract

The relation between lipoprotein(a) [Lp(a)] as an independent risk factor for coronary atherosclerosis and the severity and extension of angiographically detectable coronary atherosclerotic lesions has not been systematically evaluated. In 118 male patients (54.3 +/- 7.4 years) with suspected coronary artery disease and without a history of myocardial infarction undergoing coronary angiography, the relation between plasma Lp(a) levels and other lipoproteins and the severity and extension of coronary lesions was studied. The coronary angiograms were evaluated in a blinded manner according to three scores: vessel score (0 to 3 points for 0 to 3 vessels with stenoses > or = 70%), stenosis score (0 to 32 points; number and severity of coronary stenoses or lesions), and extent score (0 to 100 points; length-extension of all coronary lesions in relation to the total coronary vessel length). The score values obtained were analyzed for correlations with age and levels of total cholesterol (6.08 +/- 1.26 mmol/L; mean +/- SD), high-density lipoprotein cholesterol (1.04 +/- 0.33 mmol/L), low-density lipoprotein cholesterol (4.18 +/- 1.15 mmol/L), triglycerides (1.88 +/- 1.37 mmol/L), and Lp(a) in plasma (19.5 +/- 22.6 mg/dL). Bivariate correlation analysis resulted in positive correlations between Lp(a) and vessel score (P < .01), stenosis score (P < .01), and extent score (P < .05). With multivariate analyses, besides Lp(a) plasma level (nl), only patient age showed a significant correlation to all three scores used, whereas none of the lipid parameters correlated significantly with all three scores.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947596     DOI: 10.1161/01.atv.14.11.1730

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  15 in total

1.  Hypercholesterolemia and Dyslipidemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

Review 2.  Consensus statement on management of dyslipidemia in Indian subjects.

Authors:  K Sarat Chandra; Manish Bansal; Tiny Nair; S S Iyengar; Rajeev Gupta; Subhash C Manchanda; P P Mohanan; V Dayasagar Rao; C N Manjunath; J P S Sawhney; Nakul Sinha; A K Pancholia; Sundeep Mishra; Ravi R Kasliwal; Saumitra Kumar; Unni Krishnan; Sanjay Kalra; Anoop Misra; Usha Shrivastava; Seema Gulati
Journal:  Indian Heart J       Date:  2014-12-24

3.  Hypercholesterolemia and Dyslipidemia: Issues for the Clinician.

Authors:  H. Robert Superko; Nicolas A. Chronos
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

4.  Relook at lipoprotein (A): independent risk factor of coronary artery disease in north Indian population.

Authors:  Jamal Yusuf; Neeraj Yadav; Saibal Mukhopadhyay; Abhishek Goyal; Vimal Mehta; Vijay Trehan; Sanjay Tyagi
Journal:  Indian Heart J       Date:  2014-04-21

Review 5.  Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.

Authors:  Børge G Nordestgaard; Anne Langsted
Journal:  J Lipid Res       Date:  2016-09-27       Impact factor: 5.922

6.  Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.

Authors:  Brian G Kral; Rita R Kalyani; Lisa R Yanek; Dhananjay Vaidya; Elliot K Fishman; Diane M Becker; Lewis C Becker
Journal:  Am J Cardiol       Date:  2016-07-05       Impact factor: 2.778

7.  Lipoprotein (A): Better assessor of coronary heart disease risk in south Indian population.

Authors:  D Rajasekhar; K S S Saibaba; P V L N Srinivasa Rao; S A A Latheef; G Subramanyam
Journal:  Indian J Clin Biochem       Date:  2004-07

8.  Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a).

Authors:  Mariko Kyutoku; Hironori Nakagami; Hiroshi Koriyama; Futoshi Nakagami; Munehisa Shimamura; Hitomi Kurinami; Hideki Tomioka; Takashi Miyake; Tomohiro Katsuya; Ryuichi Morishita
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting?

Authors:  Alireza Khosravi; Masoud Pourmoghaddas; Fereshteh Ziaie; Arezoo Enteshari; Arsalan Khaledifa; Ahmad Bahonar
Journal:  Int J Prev Med       Date:  2011-07

Review 10.  South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.

Authors:  Latha Palaniappan; Arun Garg; Enas Enas; Henrietta Lewis; Sehrish Bari; Martha Gulati; Cristina Flores; Ashish Mathur; Cesar Molina; Jagat Narula; Shahid Rahman; Jennifer Leng; Francesca Gany
Journal:  J Community Health       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.